Clinical Trial Update: Efficacy and Safety of Toujeo® Versus Tresiba® in Insulin-Naive Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Oral Antihyperglycemic Drug(s) ± GLP-1 Receptor Agonist [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Toujeo with Tresiba in insulin-naive patients with type 2 diabetes inadequately controlled on oral medications ± GLP-1 receptor agonist;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• TOUJEO (insulin glargine)
• Tresiba (insulin degludec)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2018-09-14